DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lexxel (Enalapril Maleate / Felodipine) - Summary

 
 



USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, LEXXEL should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality.

 

LEXXEL SUMMARY

LEXXEL®
(enalapril maleate-felodipine ER)
TABLETS

LEXXEL (enalapril maleate-felodipine ER) is a combination product, consisting of an outer layer of enalapril maleate surrounding a core tablet of an extended-release felodipine formulation. Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin converting enzyme inhibitor, enalaprilat.

LEXXEL is indicated for the treatment of hypertension.

This fixed combination drug is not indicated for the initial therapy of hypertension. (See DOSAGE AND ADMINISTRATION.)

In using LEXXEL, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that enalapril (a component of LEXXEL) does not have a similar risk. (See WARNINGS, Neutropenia/Agranulocytosis.)

In considering use of LEXXEL, it should be noted that black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blacks. (See WARNINGS, Angioedema.)


See all Lexxel indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Lexxel (Enalapril / Felodipine)

Echo-Defined Pulmonary Hypertension in Multiple Myeloma
Source: Medscape Critical Care Headlines [2016.07.28]
Pulmonary hypertension is an infrequent but serious complication in multiple myeloma. What factors may suggest patients at high risk, and what are the clinical implications?
Southern Medical Journal

Move away from treating hypertension as disease
Source: Cardiovascular / Cardiology News From Medical News Today [2016.07.25]
Doctors should move away from the hypertensive model of care and towards a cardiovascular risk approach when managing blood pressure, according to a Perspective published online by the Medical...

Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health
Source: Cardiovascular / Cardiology News From Medical News Today [2016.07.19]
In a study of patients with hypertension, those with resistant hypertension - meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of...

Stroke is largely preventable, with hypertension confirmed as biggest risk factor, according to global study
Source: Hypertension News From Medical News Today [2016.07.18]
Ten potentially modifiable risk factors account for 90% of strokes worldwide, but regional variation should be considered, says study.

Prehypertension during pregnancy could lead to cardiovascular risks
Source: Hypertension News From Medical News Today [2016.06.28]
Pregnant women who experience persistent blood pressure elevations in the upper ranges of normal may be at high risk of developing metabolic syndrome and increased cardiovascular risk after giving...

more news >>


Page last updated: 2016-07-28

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015